9 in 10 Indians Face Silent Health Risks: New Data Insight

9 in 10 Indians Face Silent Health Risks: New Data Insight

Read More
Full Text
3 days back

9 in 10 Indians Face Silent Health Risks: New Data Insight


A recent large-scale preventive health analysis highlights a widespread burden of silent health risks across the Indian population. According to the Bharat Aarogyam Score, over 9 in 10 individuals show early signs of at least one health condition. Furthermore, a majority of these individuals exhibit multiple overlapping risk factors. This comprehensive study evaluated over 93 lakh health checkups conducted between 2023 and 2025. Consequently, the findings underscore the urgent need for proactive health management in the country.



Identifying Prevalent Silent Health Risks


The preventive health analysis focuses on ten major health condition groups. These include cancer risk indicators, diabetes, and heart health. Additionally, the researchers evaluated liver and kidney function, thyroid disorders, and essential vitamin levels. The data shows that health risks rarely occur in isolation. Therefore, most individuals present multiple co-existing conditions. Heart and diabetes risks specifically rise sharply in the 21 to 40 age group. In fact, heart risk doubles by the 30s. Meanwhile, diabetes risk more than doubles by the 40s. These findings suggest that silent health risks are manifesting much earlier than previously anticipated by clinical standards.



Age and Gender Variations in Health Patterns


The report provides critical insights into how health risks evolve with age and gender. Kidney-related risks increase significantly after individuals reach age 60. Conversely, thyroid imbalances show a steady rise across all age groups. This indicates a gradual accumulation of risk over time. Gender-based data also reveals notable differences. For instance, females show a significantly higher prevalence of low hemoglobin. On the other hand, males exhibit higher liver marker abnormalities and Vitamin B12 deficiency. Surprisingly, thyroid imbalance shows only a marginal difference between genders. This finding challenges common clinical assumptions regarding thyroid prevalence. Furthermore, the overall health risk trends remained largely stable over the two-year study period.



Shifting to Continuous Preventive Care


Rahul Guha, MD & CEO of Thyrocare, noted that India is unaware of its health status rather than simply being sick. Therefore, the findings emphasize the importance of early knowledge of health parameters. Medical professionals must encourage a shift from episodic treatment to continuous preventive care. Data-driven health insights allow for earlier intervention in lifestyle-related diseases. Moreover, regular health screenings are essential to identify early-onset risks before they become chronic conditions. This critical shift in the health landscape reinforces the growing importance of preventive healthcare across all age demographics.



Frequently Asked Questions


Q1: What is the Bharat Aarogyam Score?


It is a preventive health analysis based on millions of health checkups in India. It evaluates ten major health condition groups to identify early signs of non-communicable diseases.


Q2: Why are these health risks described as silent?

These risks are called silent because they often show no obvious symptoms in the early stages. However, they can lead to severe conditions like heart disease or kidney failure if left undetected.


Q3: At what age do non-communicable disease risks begin to rise significantly?

The analysis shows that risks for heart disease and diabetes begin to rise sharply as early as the 21 to 40 age group.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.


References



  1. 9 in 10 Indians Show Silent Health Risks, Says Study - ETHealthworld

  2. Thyrocare Technologies Limited. (2026). Bharat Aarogyam Score: Population Health Analysis Report (2023-2025).

  3. Indian Council of Medical Research (ICMR). (2025). Guidelines for Management of Non-Communicable Diseases in India.

"
Login to continue

More from MedShots Daily

9 in 10 Indians Face Silent Health Risks: New Data Insight
9 in 10 Indians Face Silent Health Risks: New Data Insight

Thyrocare's Bharat Aarogyam Score reveals that 9 in 10 Indians have silent health risks, with non-communicable diseases appearing as early as age 21....

3 days back

Read More
Full Text
Dietary Fibre and CVD Risk: Why Diabetes Status Changes the Narrative
Dietary Fibre and CVD Risk: Why Diabetes Status Changes the Narrative

A multiethnic study reveals that dietary fibre reduces CVD risk in non-diabetic individuals, while gut microbiota markers offer broader protection....

Today

Read More
Full Text
IUD Malposition: Why Symptoms and String Checks are Not Enough
IUD Malposition: Why Symptoms and String Checks are Not Enough

A recent study highlights that nearly half of patients with malpositioned IUDs are asymptomatic, making ultrasound essential for accurate diagnosis....

Today

Read More
Full Text
Association of SGLT2 Inhibitors with Reduced Stroke Risk in Patients with Type 2 Diabetes and Retinopathy
Association of SGLT2 Inhibitors with Reduced Stroke Risk in Patients with Type 2 Diabetes and Retinopathy

SGLT2i therapy is associated with lower stroke risk, particularly hemorrhagic stroke, in T2D patients with diabetic retinopathy, according to a 5-year study...

Today

Read More
Full Text
Bone Magnetic Resonance Imaging: From Conventional Methods to AI-Driven Solutions
Bone Magnetic Resonance Imaging: From Conventional Methods to AI-Driven Solutions

A review of bone MRI evolution, from conventional T1/T2 sequences to AI-driven synthetic CT, enhancing diagnosis for osteoporosis and osteoarthritis....

Today

Read More
Full Text
Semaglutide and Liver Outcomes in Type 2 Diabetes: A Real-World Analysis
Semaglutide and Liver Outcomes in Type 2 Diabetes: A Real-World Analysis

A population-based cohort study finds semaglutide treatment is not associated with reduced risk of liver cirrhosis or HCC in type 2 diabetes patients....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris